# Etoricoxib

## Arcoxia 60mg

| TAH Drug Code      | [OARC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OARC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute and chronic treatment of osteoarthritis (OA) and rheumatoid arthritis (RA)， treatment of acute gouty arthritis， treatment of primary dysmenorrhea， treatment of pain after dental surgery， treatment of pain after gynecological surgery.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Take with or without food. As the dose and duration of COX-2 selective inhibitor use increase， the cardiovascular risk may increase. Treatment should be done with the lowest effective daily dose for the shortest time possible. Osteoarthritis: 30 mg or 60 mg QD; max 60 mg QD. Rheumatoid arthritis: 60 mg or 90 mg QD. The lowest effective daily dose is 60 mg; max 90 mg QD. Ankylosing spondylitis: 60 mg or 90 mg QD. The lowest effective daily dose is 60 mg; max 90 mg QD. Acute gouty arthritis: 120 mg QD. Acute symptomatic period: 120 mg <= 8 days. Primary dysmenorrhea: 120 mg QD. Acute symptomatic period: 120 mg <= 8 days. Dental postoperative pain: 90 mg QD; max 90 mg QD for 3 days. Gynecological postoperative pain: 90 mg QD. The initial dose should be given before surgery; max 120 mg QD for 5 days.                                                                                                    |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Allergy to any component of this product. Congestive heart failure (NYHA II-IV). Known ischemic heart disease， peripheral artery disease， and/or cerebrovascular disease (including recent coronary artery bypass grafting or vascular repair surgery). This medication is contraindicated within 14 days following coronary artery bypass grafting (CABG). Patients with hypertension persistently above 140/90 mmHg that cannot be effectively controlled.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Weakness/fatigue， dizziness， headache， drowsiness， anxiety， insomnia， mental confusion， hallucinations， depression， restlessness， blurred vision， taste disturbances， intracranial hemorrhage， chest tightness， palpitations， angina， arrhythmia， congestive heart failure， hypertension， peripheral edema， hyperkalemia， flushing， deep vein thrombosis， bronchospasm， pulmonary embolism， shortness of breath， indigestion， heartburn， nausea， abdominal pain， vomiting， diarrhea， mouth ulcers， gastric ulcers including perforation and bleeding， hepatitis， jaundice， liver failure， elevated ALT， elevated AST， renal impairment including renal failure， thrombocytopenia， angioedema， itching， erythema， rash， urticaria， fixed drug eruptions， Stevens-Johnson syndrome， toxic epidermal necrolysis， allergic reactions， anaphylactic/anaphylactoid reactions (including shock). |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/etoricoxib-international-drug-information-concise)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

## Ecoxia F.C. Tablet 60mg

| TAH Drug Code      | [OECO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OECO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute and chronic treatment of osteoarthritis (OA) and rheumatoid arthritis (RA)， treatment of acute gouty arthritis， treatment of primary dysmenorrhea， treatment of pain after dental surgery， treatment of pain after gynecological surgery.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Ankylosing spondylitis: 90 mg orally once daily. Gout， acute: 120 mg orally once daily for up to 8 days. Osteoarthritis: 30 mg orally once daily; may increase to 60 mg once daily. Painful mouth: 90 mg orally once daily for up to 3 days after molar extraction. Rheumatoid arthritis: 90 mg orally once daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Previous hypersensitivity to etoricoxib Acute peptic ulcer disease or GI bleeding Patients with a history of bronchospasm with rhinoconjunctivitis or urticaria/angioedema associated with aspirin or other nonsteroidal antiinflammatory agents (adult-onset asthma， chronic rhinitis， nasal polyps， and chronic urticaria/angioedema predispose to these reactions) (risk of anaphylactic-like reactions). Severe renal or hepatic disease. Congestive heart failure (NYHA II-IV). Known ischemic heart disease， peripheral artery disease， and/or cerebrovascular disease (including recent coronary artery bypass grafting or vascular repair surgery). This medication is contraindicated within 14 days following coronary artery bypass grafting (CABG). Patients with hypertension persistently above 140/90 mmHg that cannot be effectively controlled.                                                                       |
| Adverse Effects    | Weakness/fatigue， dizziness， headache， drowsiness， anxiety， insomnia， mental confusion， hallucinations， depression， restlessness， blurred vision， taste disturbances， intracranial hemorrhage， chest tightness， palpitations， angina， arrhythmia， congestive heart failure， hypertension， peripheral edema， hyperkalemia， flushing， deep vein thrombosis， bronchospasm， pulmonary embolism， shortness of breath， indigestion， heartburn， nausea， abdominal pain， vomiting， diarrhea， mouth ulcers， gastric ulcers including perforation and bleeding， hepatitis， jaundice， liver failure， elevated ALT， elevated AST， renal impairment including renal failure， thrombocytopenia， angioedema， itching， erythema， rash， urticaria， fixed drug eruptions， Stevens-Johnson syndrome， toxic epidermal necrolysis， allergic reactions， anaphylactic/anaphylactoid reactions (including shock). |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/etoricoxib-international-drug-information-concise)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

